Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer

Detalles Bibliográficos
Autores principales: Nagano, Tatsuya, Tachihara, Motoko, Hazama, Daisuke, Nishimura, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475541/
https://www.ncbi.nlm.nih.gov/pubmed/32944375
http://dx.doi.org/10.21037/jtd.2020.04.34
_version_ 1783579528309768192
author Nagano, Tatsuya
Tachihara, Motoko
Hazama, Daisuke
Nishimura, Yoshihiro
author_facet Nagano, Tatsuya
Tachihara, Motoko
Hazama, Daisuke
Nishimura, Yoshihiro
author_sort Nagano, Tatsuya
collection PubMed
description
format Online
Article
Text
id pubmed-7475541
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-74755412020-09-16 Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer Nagano, Tatsuya Tachihara, Motoko Hazama, Daisuke Nishimura, Yoshihiro J Thorac Dis Editorial Commentary AME Publishing Company 2020-08 /pmc/articles/PMC7475541/ /pubmed/32944375 http://dx.doi.org/10.21037/jtd.2020.04.34 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Nagano, Tatsuya
Tachihara, Motoko
Hazama, Daisuke
Nishimura, Yoshihiro
Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
title Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
title_full Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
title_fullStr Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
title_full_unstemmed Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
title_short Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
title_sort society for translational medicine consensus (2019 edition) shows an option for postoperative management of egfr-mutant lung cancer
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475541/
https://www.ncbi.nlm.nih.gov/pubmed/32944375
http://dx.doi.org/10.21037/jtd.2020.04.34
work_keys_str_mv AT naganotatsuya societyfortranslationalmedicineconsensus2019editionshowsanoptionforpostoperativemanagementofegfrmutantlungcancer
AT tachiharamotoko societyfortranslationalmedicineconsensus2019editionshowsanoptionforpostoperativemanagementofegfrmutantlungcancer
AT hazamadaisuke societyfortranslationalmedicineconsensus2019editionshowsanoptionforpostoperativemanagementofegfrmutantlungcancer
AT nishimurayoshihiro societyfortranslationalmedicineconsensus2019editionshowsanoptionforpostoperativemanagementofegfrmutantlungcancer

Ejemplares similares